Ibrahim Mansour, MD
Interventional Cardiology · Dekalb, ILNPI 1619076619
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 32.6% of the total. Reporting peaked in 2021 at $403 and has fallen 96.2% since, to $15 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IL, where the typical reported total is $7,434.
Across 86 payments — averaging $13.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$377
- Novartis$133
- Pfizer$119
- Esperion Therapeutics, Inc.$89
- AstraZeneca$77
- Amgen$59
- plus $304 from 12 others
What the payments were for
- Food & beverage$1,13798%
- Education$212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 36 | $377 |
| Novartis | 9 | $133 |
| Pfizer | 6 | $119 |
| Esperion Therapeutics, Inc. | 5 | $89 |
| AstraZeneca | 5 | $77 |
| Amgen | 4 | $59 |
| Merck | 3 | $39 |
| Lundbeck LLC | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Boehringer Ingelheim | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Gilead | 2 | $26 |
| Vifor Pharma, Inc. | 1 | $25 |
| Medtronic | 1 | $23 |
| Cardiovascular Systems Inc. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 2 | $13 |
How this compares
$1,158 in reported general payments places this provider in the 15th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Dekalb
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
- Neal SawlaniPark Ridge$246K
- Tony de MartiniSpringfield$208K
- Bouyella ReddyMoline$172K
- David StewartChicago$169K
- Jaafer GolzarOak Lawn$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.